French Drug Policy
- 1 October 1986
- journal article
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 2 (4) , 637-642
- https://doi.org/10.1017/s0266462300003470
Abstract
French drug policy is closely controlled by the government to achieve two main purposes: to ensure therapeutic efficacy and safety, and to control pricing. Manufacturers usually price new drugs at the amount the French Sécurité Sociale (Social Security) agrees to reimburse the consumer. The specific steps a new ethical drug must go through in order to be released on the French market, and the process of negotiation between the government and the manufacturer are discussed in this paper.Keywords
This publication has 1 reference indexed in Scilit:
- Influence of low doses of naloxone on pituitary secretion in manEuropean Journal of Clinical Pharmacology, 1982